SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity

A Barbáchano1, P Ordóñez-Morán, J M García

  • 1Departamento de Biología del Cáncer, Instituto de Investigaciones Biomédicas 'Alberto Sols', Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid, Spain.

Oncogene
|June 15, 2010
PubMed

Insights

SPROUTY-2 (SPRY2) is inhibited by vitamin D in colon cancer cells. SPRY2 represses E-cadherin, promoting tumor growth and suggesting SPRY2 as a therapeutic target and marker for high-grade colon cancers.

Area of Science:

  • Molecular biology
  • Cancer research
  • Cell signaling

Background:

  • SPROUTY-2 (SPRY2) is a negative regulator of receptor tyrosine kinase signaling, impacting cell growth and differentiation.
  • Vitamin D metabolites, such as 1alpha,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)), are known to influence cellular processes.
  • E-cadherin is a crucial cell adhesion molecule often downregulated in cancer.

Purpose of the Study:

  • To investigate the regulatory relationship between SPRY2 and E-cadherin in colon cancer.
  • To explore the role of 1,25(OH)(2)D(3) in modulating SPRY2 expression and its downstream effects.
  • To determine the clinical relevance of SPRY2 and E-cadherin expression in colon cancer patients.

Main Methods:

  • Investigated SPRY2 expression in colon cancer cells treated with 1,25(OH)(2)D(3).
  • Assessed the impact of SPRY2 on E-cadherin and epithelial-to-mesenchymal transition (EMT) markers like ZEB1.
  • Analyzed SPRY2 and E-cadherin protein levels in colon cancer cell lines, xenografts, and patient tumors.

Main Results:

  • 1,25(OH)(2)D(3) inhibits SPRY2 expression in colon cancer cells via E-cadherin-dependent and -independent pathways.
  • SPRY2 represses both basal and 1,25(OH)(2)D(3)-induced E-cadherin expression, partly through ZEB1 induction.
  • SPRY2 and E-cadherin protein levels show an inverse correlation in colon cancer cell lines, xenografts, and patient samples.
  • SPRY2 is upregulated in undifferentiated, high-grade colon tumors and at the invasive front of low-grade carcinomas.

Conclusions:

  • SPRY2 promotes colon tumorigenesis by repressing E-cadherin, likely via ZEB1 induction.
  • A reciprocal regulatory loop exists between SPRY2 and E-cadherin, influencing colon cancer cell phenotype.
  • SPRY2 is a potential biomarker for high-grade colon tumors and a target for therapeutic intervention.

Related Concept Videos

Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...